title: Effects of somatostatin on cultured human mesangial cells.
abstract: The present experiments were devoted to analyzing the hypothesis that somatostatin (SS) could modulate glomerular filtration rate by interacting with mesangial cells. Studies were performed in cultured human mesangial cells, passages 3-5. Radioligand experiments demonstrated the presence in the cells of two kinds of receptors, with high (dissociation constant 14 pM. Number of sites: 426 fmol/mg) and low (dissociation constant 56 pM. Number of sites: 20, 111 fmol/mg) affinity. SS prevented in a dose-dependent manner the reduction in planar cell surface area induced by 100 nM Angiotensin II (AII). This effect was not inhibited by the blockade of the vasorelaxing prostaglandins (indomethacin, 10 microM), nitric oxide (L-N-methyl-arginine, 0.2 mM), adenylate cyclase (2,5'-dideoxyadenosine, 0.1 mM), or guanylate cyclase (Methylene blue, 30 microM; LY-83583, 10 microM), but it was potentiated by zaprinast, an inhibitor of the cyclic GMP (cGMP)-specific phosphodiesterase. SS also blocked the increase in myosin light chain phosphorylation induced by AII. SS increased cGMP synthesis by cultured human mesangial cells, an effect that seemed to be dependent on the stimulation of a particulate guanylate cyclase. Preincubation of the cells with pertussis toxin (0.5 microgram/ml) inhibited the effect of SS on the AII-dependent changes in planar cell surface area, as well as the SS-dependent cGMP stimulation. In summary, these results demonstrate the ability of SS to relax cultured human mesangial cells, thus supporting a role for this peptide in the regulation of the glomerular filtration rate. The SS-dependent mesangial cell relaxation may be due to changes in the intracellular concentrations of cGMP, as a consequence of the activation of a particulate guanylate cyclase.
authors.affiliation: Department of Physiology, Alcalá de Henares University, Madrid, Spain.
authors.forename: M L
authors.initials: ML
authors.lastname: Díez-Marqués
authors.forename: C
authors.initials: C
authors.lastname: García-Escribano
authors.forename: J
authors.initials: J
authors.lastname: Medina
authors.forename: M C
authors.initials: MC
authors.lastname: Boyano-Adanez
authors.forename: E
authors.initials: E
authors.lastname: Arilla
authors.forename: G
authors.initials: G
authors.lastname: Torrecilla
authors.forename: D
authors.initials: D
authors.lastname: Rodríguez-Puyol
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez-Puyol
mesh_terms: D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002478:Cells, Cultured; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005920:Glomerular Mesangium / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D015282:Octreotide / Q000031:analogs & derivatives / Q000378:metabolism; D011233:Precipitin Tests; D013004:Somatostatin / Q000494:pharmacology*
chemical_list: C045210:3-Tyr-octreotide; D000804:Angiotensin II; D013004:Somatostatin; D015282:Octreotide